Journal article
Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 non-structural protein 9
The Journal of biological chemistry, Vol.297(3), 101018
07/28/2021
DOI: 10.1016/j.jbc.2021.101018
PMCID: PMC8317483
PMID: 34331944
Abstract
The coronaviral non-structural protein 9 (Nsp9) is essential for viral replication; it is the primary substrate of Nsp12’s pseudokinase domain within the viral replication transcription complex, an association that also recruits other components during different stages of RNA reproduction. In the unmodified state, Nsp9 forms an obligate homodimer via an essential GxxxG protein-interaction motif, but its ssRNA-binding mechanism remains unknown. Using structural biological techniques, here we show that a base-mimicking compound identified from a small molecule fragment screen engages Nsp9 via a tetrameric Pi-Pi stacking interaction that induces the formation of a parallel trimer-of-dimers. This oligomerization mechanism allows an interchange of “latching” N-termini, the charges of which contribute to a series of electropositive channels that suggests a potential interface for viral RNA. The identified pyrrolo-pyrimidine compound may also serve as a potential starting point for the development of compounds seeking to probe Nsp9’s role within SARS-CoV-2 replication.
Details
- Title: Subtitle
- Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 non-structural protein 9
- Creators
- Dene R Littler - Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, AustraliaBiswaranjan Mohanty - Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, AustraliaShea A Lowery - Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USARhys N Colson - Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, AustraliaBenjamin S Gully - Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, AustraliaStanley Perlman - Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USAMartin J Scanlon - Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, AustraliaJamie Rossjohn - Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia
- Resource Type
- Journal article
- Publication Details
- The Journal of biological chemistry, Vol.297(3), 101018
- DOI
- 10.1016/j.jbc.2021.101018
- PMID
- 34331944
- PMCID
- PMC8317483
- NLM abbreviation
- J Biol Chem
- ISSN
- 0021-9258
- eISSN
- 1083-351X
- Publisher
- Elsevier Inc
- Grant note
- DOI: 10.13039/501100000923, name: Australian Research Council; DOI: 10.13039/501100000947, name: Australian Cancer Research Foundation
- Language
- English
- Date published
- 07/28/2021
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Infectious Disease (Pediatrics)
- Record Identifier
- 9984117145202771
Metrics
23 Record Views